Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12 Next »
Viewing Page 1 of 2 | Showing Results 1 - 5 of 6

TheraSphere HUD-A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma and/or Liver Metastases.

Inclusion Criteria: • Patients diagnosed with hepatocellular carcinoma of the liver and/or liver metastases • Able to provide informed consent •...

Rex Hoffman, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center

Phase 2, Parallel-Arm Study of MGCD265 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Activating Genetic Alterations in Mesenchymal-Epithelial Transition Factor

Inclusion Criteria: •Diagnosis of non-small cell lung cancer •Metastatic or locally advanced disease •Prior platinum chemotherapy or...

Raul Mena, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center

A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy in the Treatment of Patients of Patients with HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment

Inclusion Criteria: Histologically-proven metastatic or locally-advanced relapsed/refractory HER2+ breast cancer based on the most recently...

Raul Mena, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center

John Wayne Cancer Institute Biospecimen Repository

Jose Esteban, M.D.
  • Providence Los Angeles Research Center
  • Providence St. Joseph Medical Center (PSJMC)

Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) registry patients who are on novel oral anticoagulants in community practice.

Inclusion Criteria: •Age 18 years or older •Have been diagnosed with acute ischemic stroke and have been treated with dabigatran, rivaroxaban,...

Karen Bacosa
  • Providence Los Angeles Research Center
  • Providence St. Joseph Medical Center (PSJMC)
« Previous 12 Next »
Viewing Page 1 of 2 | Showing Results 1 - 5 of 6